Rewriting Life Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind States in the US have been slow to test newborns for genetic conditions. by Emily Mullin 2018-05-31T12:19:00-04:00
Rewriting Life A stealthy Harvard startup wants to reverse aging in dogs, and humans could be next Biologist George Church says the idea is to live to 130 in the body of a 22-year-old. by Antonio Regalado 2018-05-09T00:00:00-04:00
Rewriting Life Before he died, this biohacker was planning a CRISPR trial in Mexico Aaron Traywick and his company, Ascendance Biomedical, are connected to a website advertising a gene-therapy trial for lung cancer. by Emily Mullin 2018-05-04T17:10:00-04:00
Rewriting Life Investigators searched a million people’s DNA to find Golden State serial killer Operator of genealogy website claims “no knowledge” of police exploit on vast data set. by Antonio Regalado 2018-04-27T17:26:00-04:00
Rewriting Life These DNA testing companies are mainly trying to sell you other stuff Beware of tests offering to make “personalized” lifestyle recommendations. by Emily Mullin 2018-04-26T17:16:00-04:00
Rewriting Life Gene therapy could free some people from a lifetime of blood transfusions Correcting a genetic mutation lets beta thalassemia patients make healthy blood cells. by Emily Mullin 2018-04-18T17:18:00-04:00
Rewriting Life When curing a disease with gene therapy is bad business A drug giant turns over its pipeline of miracle drugs to a startup. by Antonio Regalado 2018-04-12T15:24:00-04:00
Rewriting Life CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys Monkey studies look encouraging but show there’s still a lot to learn about the gene-editing technology. by Emily Mullin 2018-04-11T07:00:00-04:00
Rewriting Life This company can encode your favorite song in DNA—for $100,000 It’s not cheap. But Twist Bioscience thinks storing data in genes could be the next big thing. by Bryan Walsh 2018-04-06T09:58:00-04:00
Rewriting Life CRISPR may not cause hundreds of rogue mutations after all Researchers behind a controversial paper have admitted that their results may be wrong. by Emily Mullin 2018-03-30T16:41:00-04:00
